Skip to content
by Legal Desire
16 November 2026

Latham & Watkins Advises on Vir Biotechnology’s US$150 Million Public Offering of Common Stock

Advising firms

Deal team

12 lawyers named
LawyerFirmSeniorityPracticeOffice
Drew Capurro Lead Latham & Watkins LLP Partner corporate Orange County
Greg Van Buiten Latham & Watkins LLP Associate corporate Not stated
Caitlin Nguyen Latham & Watkins LLP Associate corporate Not stated
Brock Meyer Latham & Watkins LLP Associate corporate Not stated
Heather Deixler Latham & Watkins LLP Partner regulatory Bay Area
Betty Pang Latham & Watkins LLP Partner regulatory Bay Area
Chad Jennings Latham & Watkins LLP Counsel regulatory Washington, D.C.
Kris Kenn Latham & Watkins LLP Associate regulatory Not stated
Rob Yeh Latham & Watkins LLP Counsel intellectual property San Diego
Andrew Wang Latham & Watkins LLP Associate intellectual property Not stated
Grace Lee Latham & Watkins LLP Partner tax Bay Area
Francis Shih Latham & Watkins LLP Not stated tax Not stated

9 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 150m (US$150 million)
What the figure measures
Issue size
Client
Not stated
Counterparties
Vir Biotechnology, Inc. (Issuer)